Exonic is an AI-native cell and gene therapeutics company.
We program DNA sequences to be context-aware, unlocking new kinds of genetic therapies.
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
We use human data and AI to develop better drugs faster.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Medicinal Chemistry powered by Machine Learning
Quick facts:
HQ: Boston, MA, United States
What they do:
Targeting Cancer with Click Chemistry
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Using the immune system to cure disease
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Next-generation mRNA platform to solve cancer, COVID and climate.
Quick facts:
HQ: Boston, MA, United States
Exonic is an AI-native cell and gene therapeutics company.
San Francisco, CA, United States
3 employees, according to the company profile.
There are no funding rounds for Exonic in our data.
Similar startups: Numerion Labs, Verge Genomics, and PostEra.